Home 2023

Cell therapy

Forwarding Allogeneic Therapies
Bioprocessing

Forwarding Allogeneic Therapies

John Sterling -
0
Increasing Access to Cell Therapies
Bioprocessing

Increasing Access to Cell Therapies

John Sterling -
0
Analytical Technologies Evolve with Cell Therapies
Bioprocessing

Analytical Technologies Evolve with Cell Therapies

John Sterling -
0
Meeting on the Mesa: Without Ethics, Cell and Gene Therapy Will Fail
Drug Discovery

Meeting on the Mesa: Without Ethics, Cell and Gene Therapy Will Fail

Jonathan D Grinstein, PhD -
0
Meeting on the Mesa: How to Bring Cell and Gene Therapies to Market
Bioprocessing

Meeting on the Mesa: How to Bring Cell and Gene Therapies to Market

Jonathan D Grinstein, PhD -
0
If Donor Cell Infusions Precede Organ Transplants, Less Immunosuppression May Be Needed
Featured

If Donor Cell Infusions Precede Organ Transplants, Less Immunosuppression May Be Needed

Sophia Ktori -
0
Automated Production for Cell and Gene Therapy Developers
Bioprocessing

Automated Production for Cell and Gene Therapy Developers

John Sterling -
0
CTMC Partners with ScaleReady for Greater Patient Accessibility
Bioprocessing

CTMC Partners with ScaleReady for Greater Patient Accessibility

John Sterling -
0
Synthetic DNA and RNA Can Open New Manufacturing Workflows
Bioprocessing

Synthetic DNA and RNA Can Open New Manufacturing Workflows

Kathy Vuksanaj -
0
De-risking Cell Therapy New Product Introduction
Bioprocessing

De-risking Cell Therapy New Product Introduction

Kathy Vuksanaj -
0
123...93Page 1 of 93
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.